This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
The regulator said the buyout “would lead to a highly concentrated market for ou...
The post Reveleum receives investment from NEC X to improve medical record mana...
Closing the gap in health interventions between men and women could add $1tn to ...
The FDA has granted clearance to Qiagen’s QIAstat-Dx Gastrointestinal Panel 2 Mi...
Vitestro has unveiled Aletta, claimed to be the “world's first” Autonomous Robot...
Illumina is not banned from operating in the country and will continue to serve ...
A ‘tumour-on-chip’ model on PDAC has been developed to allow insights into inter...
Cerus Corporation has secured CE mark approval for its INT200, a LED-based illum...
The money will support an ongoing pivotal trial of 4C Medical Technologies' tran...
4C Medical Technologies has closed its Series D financing round. which was led b...
The US Food and Drug Administration (FDA) has issued an early alert over a ‘pote...
New York City’s Mount Sinai has become the first hospital in the US to perform a...
Post-authorisation safety studies (PASS) are often seen simply as a regulatory n...
The European orphan drug market is growing and is already comparable in size and...
With orphan drugs typically being high value, the potential risk of stock losses...
Foresight Diagnostics has launched the PRECISE-HL trial, which will use the Fore...
The post China bans Illumina sequencer imports as US trade war intensifies appe...
The post Duodenal mucosal resurfacing: Treatments for metabolic diseases appear...
The NHS in the UK is rolling out a new AI tool to support out of hospital care, ...
The 25% US tariffs on Canada and Mexico have put into question a three-decade-lo...
Philips stopped selling its Tack endovascular system because of cases where addi...
Olympus is set to launch the Retentia HemoClip to assist gastrointestinal (GI) e...
Epredia has received 510(k) clearance from the FDA for the E1000 Dx, a scanner d...
Cadrenal Therapeutics has partnered with Abbott for the TECH-LVAD trial to asses...